Dana Goodwin
Adult Health · Birmingham, ALNPI 1477972511
Payments from drug & device makers
Across 32 payments — averaging $65.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mylan Specialty L.p.$867
- Electromed, Inc.$588
- Insmed, Inc.$338
- Philips North America LLC$144
- Genentech USA, Inc.$75
- Baxter Healthcare$47
- plus $48 from 2 others
What the payments were for
- Consulting fees$85040%
- Food & beverage$1,25860%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mylan Specialty L.p. | 2 | $867 |
| Electromed, Inc. | 15 | $588 |
| Insmed, Inc. | 5 | $338 |
| Philips North America LLC | 2 | $144 |
| Genentech USA, Inc. | 3 | $75 |
| Baxter Healthcare | 2 | $47 |
| Alcresta Therapeutics, Inc. | 2 | $30 |
| Pfizer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TOBI Podhaler$850
- Arikayce$256
How this compares
$2,108 in reported general payments places this provider in the 75th percentile of 308 adult health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrikaftaElexacaftor/Tezacaftor/Ivacaft | 163 | $4,172,780 |
| CaystonAztreonam Lysine | 20 | $234,813 |
| ZenpepLipase/Protease/Amylase | 16 | $140,660 |
| CreonLipase/Protease/Amylase | 15 | $79,512 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $34,365 |
| Advair HfaFluticasone Propion/Salmeterol | 25 | $8,658 |
| Spiriva RespimatTiotropium Bromide | 12 | $7,944 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 20 | $5,103 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $2,638 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 109 | $2,628 |
| Azithromycin | 68 | $2,482 |
| Wixela InhubFluticasone Propion/Salmeterol | 13 | $2,331 |
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 11 | $883 |
| Ventolin HfaAlbuterol Sulfate | 12 | $630 |
| Fluticasone Propionate | 30 | $503 |
Paid to pharmacies, not to this prescriber.
Other adult health in Birmingham
- Lanier OhareBirmingham$42K
- Jessica WrightBirmingham$33K
- Sara HopperBirmingham$21K
- Andrea SuttonBirmingham$21K
- Laura RomundstadBirmingham$10K
- Jane DavisBirmingham$9K
- Anissa ThomasBirmingham$8K
- Chelsey KahlerBirmingham$5K
- Mary WadeBirmingham$5K
- Merry WoodsBirmingham$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.